Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-21

Clinical Trial Update: Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

An ongoing Phase 2 clinical trial to assess the efficacy, safety, and tolerability of FBL-MTX in patients with rheumatoid arthritis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FBL-MTX

Snippet

Sponsor: SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd | Conditions: Rheumatoid Arthritis | Phase 2 | Status: RECRUITING